Biosimilars face barriers to broader acceptanceNovember 4, 2016Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisBusiness of Medicine
Intravitreal sirolimus proves effective in reducing noninfectious uveitis inflammationOctober 31, 2016SpondyloarthropathiesAnkylosing spondylitis
TNF inhibitors’ effect on ankylosing spondylitis progression may be greatest after 6 yearsOctober 12, 2016Ankylosing spondylitisSpondyloarthropathies
Severe joint pain in adults with arthritis continues to riseOctober 11, 2016GoutLupus & Connective Tissue DiseasesOsteoarthritisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Most children with JIA get different diagnosis as adultsOctober 4, 2016Ankylosing spondylitisMixed TopicsPediatricsPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
FDA approves biosimilar adalimumabSeptember 27, 2016PediatricsPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Biosimilar version of etanercept gains FDA approvalAugust 30, 2016Ankylosing spondylitisPediatricsRheumatoid ArthritisSpondyloarthropathies
Ixekizumab improved psoriatic arthritis in patients who had not taken biologicsAugust 29, 2016Spondyloarthropathies
Ankylosing spondylitis patients develop multiple comorbidities after diagnosisAugust 17, 2016SpondyloarthropathiesAnkylosing spondylitis
MRI now anchors spondyloarthritis diagnosisAugust 14, 2016SpondyloarthropathiesAnkylosing spondylitis
Revised axial spondyloarthritis classification criteria remain elusiveAugust 8, 2016SpondyloarthropathiesAnkylosing spondylitis
Concurrent fibromyalgia intensifies ankylosing spondylitis symptomsAugust 1, 2016SpondyloarthropathiesPainAnkylosing spondylitis
